Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC

Expert commentary by Drs Matthew Gubens, a thoracic oncologist, and Craig Mackinnon, an anatomical and molecular pathologist, on the current and emerging role and importance of biomarker testing in NSCLC.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: July 11, 2022

Expert commentary by Matthew Gubens, MD, MS, a thoracic oncologist, and Craig Mackinnon, MD, PhD, an anatomical and molecular pathologist, on the recent FDA approval of trastuzumab deruxtecan for previously treated patients with HER2 mutation–positive advanced NSCLC.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: September 12, 2022

In this commentary, Matthew Gubens, MD, MS, a thoracic oncologist, and Craig Mackinnon, MD, PhD, an anatomical and molecular pathologist, address frequently asked questions about the importance of biomarker testing in NSCLC.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: October 17, 2022

In this commentary, Drs Matthew Gubens, a thoracic oncologist, and Craig Mackinnon, an anatomical and molecular pathologist, address frequently asked questions about the importance of biomarker testing in NSCLC.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: August 31, 2022

Learn how experts optimally test for biomarkers in patients with NSCLC in this interactive text module with multidisciplinary perspectives from Matthew Gubens, MD, MS, a thoracic oncologist, and Craig Mackinnon, MD, PhD, an anatomical and molecular pathologist, and then use the results to integrate novel and emerging targeted therapies effectively and safely into clinical practice care.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: July 6, 2022 Expired: No longer available for credit

Review this slideset on current recommendations for evidence-based biomarker testing to guide treatment decision-making for patients with NSCLC from Matthew Gubens, MD, MS, and Craig Mackinnon, MD, PhD.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: July 6, 2022

Download these slides from a live webinar to learn more about the current guidelines and expert recommendations for evidence-based biomarker testing to guide treatment decision-making in the management of patients with NSCLC.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: July 29, 2022

Download this evidence-based infographic to serve as a helpful guide for biomarker testing before treatment decision-making for patients with NSCLC.